Linical Co., Ltd. (TYO:2183)
207.00
+1.00 (0.49%)
Aug 26, 2026, 3:30 PM JST
Linical Company Description
Linical Co., Ltd., a global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide.
The company offers drug discovery consulting services, such as market analysis and research of products in development, regulatory affairs, and licensing support.
It also provides clinical trial evaluation, statistical analysis, medical writing, pharmacovigilance, clinical monitoring, and contract medical affairs services.
The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Linical Co., Ltd.
| Country | Japan |
| Founded | 2005 |
| Industry | Specialty Business Services |
| Sector | Industrials |
| Employees | 577 |
| CEO | Kazuhiro Hatano |
Contact Details
Address: Shin-Osaka Brick Building Osaka, 532-0003 Japan | |
| Phone | 81 6 6150 2582 |
| Website | linical.com |
Stock Details
| Ticker Symbol | 2183 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3974530002 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Kazuhiro Hatano | Chief Executive Officer |
| Akihiro Takahashi | Chief Financial Officer |